WASHINGTON, DC, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- The journey of helping a child find their voice is ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

We existed in our own world that day, absorbing information we never wanted to learn. At one point, while I was crying ...

As Kool & the Gang's "Celebration" played outside, children from the Special Learning Center's SKIP Clinic paraded out of it ...

Olatec Therapeutics, Inc. ("Olatec"), a clinical stage biotechnology company leading the development of specific NLRP3 inhibitors, presented preclinical data at The Michael J. Fox Foundation (MJFF) ...

Scientists have found that a common oral bacterium known as the causative agent of tooth decay can affect the brain and ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

When Jorie Kraus was diagnosed with an incurable rare disease, two young researchers created an AI tool to find a treatment.

Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...

SLP, is the owner of Speech Specialists LLC in Millstone Township, New Jersey, and a dedicated speech-language pathologist ...

Explore Duopa, an advanced Parkinson's disease treatment that uses carbidopa-levodopa gel infusion for steady dopamine levels, reducing motor fluctuations effectively.

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...